L
Laurence Kennedy
Researcher at Cleveland Clinic
Publications - 87
Citations - 2932
Laurence Kennedy is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Acromegaly & Diabetes mellitus. The author has an hindex of 30, co-authored 87 publications receiving 2693 citations. Previous affiliations of Laurence Kennedy include University of Miami & University of Florida.
Papers
More filters
Journal ArticleDOI
Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study.
H. M. Whitehead,Colin Boreham,Edwin M. Mcllrath,Brian Sheridan,Laurence Kennedy,A. Brew Atkinson,David R. Madden +6 more
TL;DR: The study aimed to study the effect of biosynthetlc growth hormone replacement in growth hormone deficient adults and found it to be a positive replacement for GH.
Journal ArticleDOI
Impact of Active Versus Usual Algorithmic Titration of Basal Insulin and Point-of-Care Versus Laboratory Measurement of HbA1c on Glycemic Control in Patients With Type 2 Diabetes The Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial
TL;DR: In a predominantly primary care setting, addition of insulin glargine using a simple algorithm achieved significant improvements in glycemic control in patients with type 2 diabetes in all four study arms.
Journal ArticleDOI
Assessment of endocrine function after transsphenoidal surgery for Cushing's disease
David R. McCance,D. S. Gordon,T. F. Fannin,David R. Hadden,Laurence Kennedy,Brian Sheridan,A. B. Atkinson +6 more
TL;DR: The endocrine outcome after transsphenoidal surgery for Cushing's disease was assessed and the prognosis for patients with the disease was good.
Journal ArticleDOI
Underdiagnosis of Peripheral Neuropathy in Type 2 Diabetes
TL;DR: The GOAL A1C study compared the impact of point of care versus laboratory A 1C testing and weekly versus less frequent insulin titration monitoring on glycemic control in patients with type 2 diabetes adding insulin glargine to existing oral antidiabetic therapy.
Journal ArticleDOI
Primary and central hypothyroidism after radiotherapy for head-and-neck tumors.
TL;DR: Clinical and subclinical manifestations of late radiation toxicity were observed in the thyroid and hypothalamic-pituitary axis, and although CH did not indicate a dependence on fractionation, adjuvant chemotherapy, or total dose to the pituitary, PH showed a Dependence on the total doses to the thyroid gland.